Keros Therapeutics, Inc. ($KROS)
Filing Information
| Accession Number | 0001732369-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 9, 2026 |
| Document Date | Jan 7, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
62,500
Total Value
$0.00
P&L
+inf% (+$688,462.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Employee Stock Option (right to buy) | Derivative | Jan 7, 2026 | Grant/Award | 62,500 | $0.00 | $0.00 | 62,500 | Direct | โ | View Details |